{"paper_id":"113e66df-9f4e-4b86-b995-81ae2f382f28","body_text":"Abstract\nThe aim of this study was to determine the effects of adenosine triphosphate (ATP) in a rat endometriosis model. After surgical induction of endometriosis, 3 rats were killed, and explants were measured in the remaining 19 rats, which were then randomly assigned to 4 groups. Group 1 (n = 4) received normal saline (2 mL/d intragastric [IG]), group 2 (n = 4) gestrinone (0.5 mg/kg/d IG), group 3 (n = 5) ATP (3.4 mg/kg/d IG), and group 4 (n = 6) ATP (1.0 mg/kg/d; intramuscularly), respectively. Four weeks after medication, they were euthanized to evaluate histological features of explants and eutopic uterine tissues. To test the effect of ATP on the growth of eutopic endometrium stromal cells, proliferation rates of hEM15A cells at 24, 48, and 72 hours after treatment with different concentrations of ATP and vehicle control were detected with the Cell Counting Kit-8 (CCK-8) method. There was a significant difference between pretreatment and posttreatment volumes within group 2 (positive control; P = .048) and group 4 (P = .044). On condition that pretreatment implant size was similar in both groups (P = .516), regression of explants in group 4 was significantly higher than that in group 1 (negative control; P = .035). Epithelial cells were significantly better preserved in group 1 than in group 3 (P = .008) and group 4 (P = .037). The CCK-8 assay showed no significant difference in proliferation among hEM15A cells treated with ATP and controls. These results suggest that ATP regresses endometriotic tissues in a rat endometriosis model but has no impact on the growth of eutopic endometrium stromal cells.\nSimilar content being viewed by others\nReferences\nJohnson NP, Hummelshoj L. Consensus on current management of endometriosis. Hum Reprod. 2013;28(11):1552–1568.\nSun-Wei G. Recurrence of endometriosis and its control. Hum Reprod. 2009;15(4):441–461.\nGiudice LC.Clinical practice: endometriosis. N Engl J Med. 2010; 362(25):2389–2398.\nZhao Y, Liu YN, Li Y, et al. Identification of biomarkers for endometriosis using clinical proteomics. Chin Med J (Engl). 2015;128(4):520–527.\nPestov NB, Ahmad N, Korneenko TV, et al. Evolution of Na, K-ATPase beta m-subunit into a coregulator of transcription in placental mammals. Proc Natl Acad Sci. 2007;104(27):11215–11220.\nZhang H, Niu Y, Feng J, Guo H, Ye X, Cui H. Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls. Fertil Steril. 2006;86(2):274–282.\nChen Y, Yi YH, Han HJ, et al. The establishment and identification of human endometriosis-derived immortalized eutopic endometrium stromal cell line. Chin J Clin Obstet Gynecol. 2014;15(1):60–63.\nJones RC. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol (Copenh). 1984;106(2):282–288.\nVernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694.\nHu CP, Wang ZG, Ji XY, Wang Y, Cao P. Comparison of endometriosis model establishment methods in rat. Chin J Comp Med. 2009;19(10):44–46.\nUygur D, Aytan H, Zergeroglu S, Batioglu S. Leflunomide—an immunomodulator—induces regression of endometrial explants in a rat model of endometriosis. J Soc Gynecol Investig. 2006;13(5):378–383.\nKeenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR, Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril. 1999;72(1):135–141.\nSampson J. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3(2):93–110.\nMehasseb MK, Taylor AH, Pringle JH, Bell SC, Habiba M. Enhanced invasion of stromal cells from adenomyosis in a three-dimensional coculture model is augmented by the presence of myocytes from affected uteri. Fertil Steril. 2010;94(7):2547–2551.\nStagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene. 2010;29:5346–5358.\nZheng LM, Zychlinsky A, Liu CC, Ojcius DM, Young JD. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol. 1991;112(2):279–288.\nBurnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev. 2006;58(1):58–86.\nWang DJ, Huang NN, Heppel LA. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol. 1992;153(2):221–233.\nChen Y, Corriden R, Inoue Y, et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science. 2006;314(5806):1792–1795.\nZhang Y, Chin-Quee K, Riddle RC, Li Z, Zhou Z, Donahue HJ. BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression. Biores Open Access. 2013;2(2):77–83.\nZhang H, Feng J, Chang XH, Li ZX, Wu XY, Cui H. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of endometriosis. Chin Med J (Engl). 2009;122(4):373–376.\nMatsuzaki S, Darcha C. Adenosine triphosphate-binding cassette transporter G2 expression in endometriosis and in endometrium from patients with and without endometriosis. Fertil Steril. 2012;98(6):1512–1520.\nMasuda H, Matsuzaki Y, Hiratsu E, et al. Stem cell-like properties of the endometrial side population: implication in endometrial regeneration. PLoS One. 2010;5(4):e10387.\nOliveira FR, Dela Cruz C, Del Puerto HL, Vilamil QT, Reis FM, Camargos AF. Stem cells: are they the answer to the puzzling etiology of endometriosis? Histol Histopathol. 2012;27(1):23–29.\nSchwab KE, Chan RW, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril. 2005;84(suppl 2):1124–1130.\nSasson I, Taylor H. Stem cells and the pathogenesis of endometriosis. NY Acad Sci. 2008;1127:106–115.\nPestov NB, Zhao H, Basrur V, Modyanov NN. Isolation and characterization of BetaM protein encoded by ATP1B4—a unique member of the Na, K-ATPase β-subunit gene family. Biochem Biophys Res Commun. 2011;412(4):543–548.\nSiegel PM, Massagué J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003;3(11):807–821.\nJones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction. 2006;132(2):217–232.\nPolli V, Bulletti C, Galassi A, et al. Transforming growth factor-beta 1 in the human endometrium. Gynecol Endocrinol. 1996;10(5):297–302.\nKüpker W, Schultze-Mosgau A, Diedrich K. Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update. 1998;4(5):719–723.\nOosterlynck DJ, Meuleman C, Waer M, Koninckx PR. Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol. 1994;83(2):287–292.\nOmwandho CO, Konrad L, Halis G, Oehmke F, Tinneberg HR. Role of TGF-betas in normal human endometrium and endometriosis. Hum Reprod. 2010;25(1):101–109.\nSaito A, Osuga Y, Yoshino O, et al. TGF-β1 induces proteinase-activated receptor 2 (PAR2) expression in endometriotic stromal cells and stimulates PAR2 activation-induced secretion of IL-6. Hum Reprod. 2011;26(7):1892–1898.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nZhang, C., Gao, L., Yi, Y. et al. Adenosine Triphosphate Regresses Endometrial Explants in a Rat Model of Endometriosis. Reprod. Sci. 23, 924–930 (2016). https://doi.org/10.1177/1933719115625847\nPublished:\nIssue date:\nDOI: https://doi.org/10.1177/1933719115625847","source_license":"CC0","license_restricted":false}